Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Keros Therapeutics (KROS) Prepaid Assets (2019 - 2025)

Keros Therapeutics (KROS) has disclosed Prepaid Assets for 7 consecutive years, with $2.4 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Prepaid Assets rose 65.31% year-over-year to $2.4 million, compared with a TTM value of $2.4 million through Dec 2025, up 65.31%, and an annual FY2025 reading of $2.4 million, up 65.31% over the prior year.
  • Prepaid Assets was $2.4 million for Q4 2025 at Keros Therapeutics, down from $2.7 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $21.7 million in Q1 2025 and bottomed at $1.0 million in Q4 2023.
  • Average Prepaid Assets over 5 years is $5.4 million, with a median of $3.4 million recorded in 2021.
  • The sharpest move saw Prepaid Assets skyrocketed 3534.62% in 2021, then crashed 85.1% in 2023.
  • Year by year, Prepaid Assets stood at $3.4 million in 2021, then surged by 97.73% to $6.7 million in 2022, then plummeted by 85.1% to $1.0 million in 2023, then skyrocketed by 44.86% to $1.4 million in 2024, then soared by 65.31% to $2.4 million in 2025.
  • Business Quant data shows Prepaid Assets for KROS at $2.4 million in Q4 2025, $2.7 million in Q3 2025, and $21.7 million in Q1 2025.